ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Malignancy"

  • 2017 American Transplant Congress

    Long-Term Malignancy Risk in Kidney Transplant Recipients Treated with Cyclophosphamide Pre-Transplant for Native Glomerular Disease.

    J. Mills,1 M. Jorgenson,1 J. Fose,1 B. Astor,2 S. Panzer.2

    1Pharmacy, UW Health, Madison, WI; 2Nephrology, UW Health, Madison, WI

    Purpose: To evaluate the incidence of malignancy in kidney transplant recipients who previously received cyclophosphamide for treatment of native glomerular disease.Methods: Single center study of…
  • 2017 American Transplant Congress

    Solid Organ Cancer After Kidney Transplantation: Risk Factors and Long Term Impact.

    A. Buxeda, D. Redondo, M. Pérez-Sáez, A. Bartolomé, M. Mir, A. Pascual, A. Sans, M. Crespo, J. Pascual.

    Nephrology Department, Hospital del Mar, Barcelona, Spain

    Cancer after kidney transplant (KT) is the only cause of death that is increasing. We analyzed incidence, risk factors and characteristics of postKT solid cancers…
  • 2017 American Transplant Congress

    Significance of Atypical Cytology in the Evaluation of Patients with End Stage Renal Disease for Transplantation.

    J. Law, O. Ali, H. Brar, P. Luke, A. Sener.

    Urology, Western University, London, ON, Canada

    INTRODUCTION AND OBJECTIVES: Renal transplantation is the most optimal method of treating patients with end-stage renal disease (ESRD). As part of their routine malignancy screening,…
  • 2017 American Transplant Congress

    Prevalence and Clinical Outcomes in Kidney Transplant Patients with Viral and Fungal Opportunistic Infections and Malignancy.

    M. Lubetzky, N. Hayde, L. Kamal, M. Ajaimy, P. Bedi, G. Deboccardo, E. Akalin.

    Montefiore Medical Center, Bronx

    Opportunistic infections and malignancy after kidney transplant (KTX) are associated with increased morbidity and mortality. We aimed to assess predictors and clinical outcomes in patients…
  • 2017 American Transplant Congress

    Conversion from Calcineurin Inhibitor to Sirolimus in Kidney Transplantation Recipients with Malignancy.

    J. Yoon, S. Kang, S. Kim, C. Baeck, H. Kim, S.-K. Park.

    Nephrology, Asan Medical Center, Seoul, Republic of Korea

    Background: Kidney transplant recipients are at an increased risk of malignancy for various reasons, such as the chronic use of calcineurin inhibitor (CNI). Sirolimus (SRL),…
  • 2017 American Transplant Congress

    Incidence and Risk Factors for Cervical Dysplasia Associated to Human Papillomavirus Infection in Women with Kidney Transplant.

    I. Parra-Avila, J. Alberu, L. Marino-Vazquez, L. Morales-Buenrostro, R. Rosado-Canto.

    Department of Nephrology and Transplant, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

    Introduction: Women with kidney transplant (KT) have an increased risk for Human Papillomavirus (HPV) infection, which is related to cervical cancer, reaching an incidence of…
  • 2017 American Transplant Congress

    BK Polyoma Virus and Malignancy: Cause or Co-Incidence?

    R. Prashar, A. Shah, D. Stewart, S. Williamson, A. Patel.

    Henry Ford Transplant Institute, Detroit, MI

    BackgroundThe WHO agency for cancer research has classified BKV as "possibly carcinogenic".The etiological role of BKV in human cancer, however,remains controversial.We present 5 cases of…
  • 2017 American Transplant Congress

    Nonmelanoma Skin Cancer Rates Are Not Affected by Chronic HIV(+) or HCV(+) Infection in Organ Transplant Recipients.

    K. Nadhan, E. Usedom, S. Shipman, A. Doyle, G. Malat, E. Buchanan, C. Chung.

    Dermatology, Drexel, Philadelphia

    Purpose: HIV and HCV are two immune dysregulatory processes that may exacerbate the risk of nonmelanoma skin cancer (NMSC) in organ transplant recipients (OTR), a…
  • 2017 American Transplant Congress

    High-Risk Human Papillomavirus Associated with Genital Squamous Cell Carcinoma in Nonwhite Organ Transplant Recipients.

    K. Nadhan,1 M. Larijani,1 L. Ogrich,1 C. Shaver,1 A. Doyle,2 C. Chung.1

    1Dermatology, Drexel University, Philadelphia, PA; 2Internal Medicine, University of Virginia, Charlottesville, VA

    Purpose: Squamous cell carcinoma (SCC) confers significantly increased mortality in both solid organ transplant recipients (OTR) and the immunocompetent nonwhite population. In the latter, a…
  • 2017 American Transplant Congress

    Prevalence of Cutaneous Disease in Solid Organ Transplant Recipients: A 5-Year Study from a Medical -Surgical Transplant Dermatology Center.

    R. Allawh, A. Weiffenbach, K. Nadhan, M. Abdelmalek, C. Cusack, C. Chung.

    Dermatology, Drexel University College of Medicine, Philadelphia, PA

    Background: Solid organ transplant recipients (OTR) on chronic immunosuppression exhibit heightened risk of developing a myriad of cutaneous manifestations compared to non-transplant patients, including cutaneous…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 20
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences